Action Alert! If they’re successful, the price of bioidentical hormone replacement therapy could go through the roof. And you may not be able to get the therapy in the right form any longer. In 2014, TherapeuticsMD, a drug company specializing in women’s healthcare, was granted two new patents for the company’s combination bioidentical-estradiol-and-progesterone drug. The…Details
Last year, the Drug Quality and Security Act, or DQSA, sponsored by Big Drug Companies, gave the FDA increased authority over compounding pharmacies, and the agency has responded by trying to regulate them out of existence. The new legislation passed by Congress in the December 2015 Omnibus Bill will temporarily help to save Estriol and…Details
The patients of Naturopathic Physicians derive tremendous benefit from safely compounded medications that are made available or administered to them in the physician’s office (known as “office use”). Nutritional, herbal, homeopathic and Bio-Identical Hormone Replacement medications are compounded to meet unique patient needs. These medications are not available from large pharmaceutical manufacturers that do not…Details
On October 20th, 2014, I told you about new legislation that has placed onerous new restrictions on Compounding Pharmacies. Compounding Pharmacies can no longer sell Bio-Identical Hormones in bulk to doctors office’s. Each formulation must be prescribed individually for a specific patient Each compounded medication must be made individually by hand for each patient Supplies…Details
Sadly, the Drug Quality and Security Act is a deviously misnamed attempt by big drug companies to put its competition out of business. It became law on November 27, 2013, after being signed by President Obama. Unfortunately, it seems Congress, influenced by big pharmacy’s big lobbying dollars, wanted to make the appearance of repremanding the FDA for…Details
Action Alert! Help us stop deceptive new legislation sponsored by Big Pharma.
On April 26, the Senate Committee on Health, Education, Labor, and Pensions (HELP) released draft legislation that would “clarify” the FDA’s ability to regulate both compounding pharmacies and the compounded medications themselves.
It’s our understanding that the draft bill was written with the specific intent of giving the FDA broad authority to remove compounded medications from the market in one of two ways: either by putting bulk ingredients on a list of “banned” compounded drugs, or by redefining compounded variations of approved drugs as illegal “copies.”
The way the bill is written, a compounded medication—like the low-cost natural compounded thyroid, instead of Synthroid (synthetic levothyroxine), or Estriol, the bioidentical hormone that can be used instead of Pfizer’s dangerous (and not bioidentical) Prempro—could be banned.Details